Charu Gandotra to Heart Failure
This is a "connection" page, showing publications Charu Gandotra has written about Heart Failure.
Connection Strength
0.972
-
Gandotra C, Clark J, Liu Q, Senatore FF, Rose M, Zhang J, Stockbridge NL. Heart Failure Population with Therapeutic Response to Sacubitril/Valsartan, Spironolactone and Candesartan: FDA Perspective. Ther Innov Regul Sci. 2022 01; 56(1):4-7.
Score: 0.543
-
Butler J, Usman MS, Gandotra C, Salman A, Farb A, Thompson AM, Stockbridge N, Zeller C, Folkvaljon F. Patient-Reported Outcomes as End Points in Heart Failure Trials. Circulation. 2025 Apr 15; 151(15):1111-1125.
Score: 0.173
-
Blumer V, Januzzi JL, Lindenfeld J, Solomon SD, Psotka MA, Carson PE, Bristow MR, Abraham WT, Gandotra C, Saville BR, O'Connor C, Fiuzat M. Heart?Failure Drug Development Over?the?Eras: From the Heart?Failure Collaboratory. JACC Heart Fail. 2024 Nov; 12(11):1803-1813.
Score: 0.164
-
Patel T, Tesfaldet B, Gandotra C. Pooled patient level data are better suited than study level data to investigate the link between dipeptidyl peptidase-4 inhibitors and the risk of heart failure in type 2 diabetes. BMJ. 2016 May 24; 353:i2920.
Score: 0.093